The objective of the proposed work is to design potent multivalent ligands that influence the differentiation of adult neural stem cells (NSCs) and human pluripotent stem cells (hPSCs) based on a biomimetic strategy - multivalency. Cellular signal transduction can often begin with the multivalent binding of ligands, either secreted or cell-surface tethered, to target cell receptors, leading to receptor clustering. The capacity to control multivalent interactions and thereby modulate key signaling events within living systems is, however, currently very limited. While antibody-induced ligand or receptor clustering has been achieved, this method is not well- controlled, efficient, or readily reproducible. Intracellulr targets can be clustered by the small-molecule dependent dimerization of repeated inducible dimerizing domains, but this approach involves overexpressing fusion proteins and is not readily applicable for endogenous ligands or receptors. The use of synthetic multivalent ligands is a promising approach to control and to elucidate fundamental mechanisms in cellular signaling. If such multivalent ligands could be designed to activate key signaling pathways and thereby control stem cell fate in vitro and in vivo, they could serve as both powerful biological tools and as potent therapeutics.
The first aim of the proposed work is to harness multivalent ephrin conjugates to study mechanisms by which Eph-ephrin signaling regulates cell fate decisions in neural stem cells and pluripotent stem cells. Within this aim, we will conduct a structure-function analysis of ephrin multivalency in signaling and stem cell differentiation, as well as engineer peptide-based multivalent ligands for potent activation of Eph-ephrin signaling in vitro and in vivo.
Our second aim i s to determine whether multivalent conjugates can be engineered to activate Wnt signaling in NSCs, which will be achieved with a combination of engineering peptide-based multivalent ligands and characterizing their signaling properties in vitro and in vivo. We anticipate that the resulting multivalent ephrin and Wnt ligands will serve as potent bioactive materials for controlling stem cell fate decisions, a capability that would be significan for mechanistic investigations in stem cell and developmental biology in vitro and in vivo, as well as for applications including enhanced cell culture systems, pharmacology and toxicology screens, and regenerative medicine approaches to restore organ function.
The proposed work will focus on the design of potent multivalent ligands that will influence the differentiation of adult neural stem cells (NSCs) and human embryonic stem cells (hESCs). These studies will contribute to a fundamental understanding of multivalent biorecognition, and of the mechanisms of cell fate decisions in NSCs and hESCs. The research is also relevant to public health because the design of multivalent ligands represents a powerful approach for influencing stem cell proliferation and differentiation for applications ranging from cell replacement therapies to regenerative medicine approaches to restore organ function.
|Ekerdt, Barbara L; Fuentes, Christina M; Lei, Yuguo et al. (2018) Thermoreversible Hyaluronic Acid-PNIPAAm Hydrogel Systems for 3D Stem Cell Culture. Adv Healthc Mater 7:e1800225|
|Dong, Meimei; Spelke, Dawn P; Lee, Young Kwang et al. (2018) Spatiomechanical Modulation of EphB4-Ephrin-B2 Signaling in Neural Stem Cell Differentiation. Biophys J 115:865-873|
|Mukherjee, Abhirup; Dhar, Neha; Stathos, Mark et al. (2018) Understanding How Wnt Influences Destruction Complex Activity and ?-Catenin Dynamics. iScience 6:13-21|
|Kang, Phillip; Kumar, Sanjay; Schaffer, David (2017) Novel biomaterials to study neural stem cell mechanobiology and improve cell-replacement therapies. Curr Opin Biomed Eng 4:13-20|
|Mukherjee, Abhirup; Repina, Nicole A; Schaffer, David V et al. (2017) Optogenetic tools for cell biological applications. J Thorac Dis 9:4867-4870|
|Varner, Chad T; Rosen, Tania; Martin, Jacob T et al. (2015) Recent advances in engineering polyvalent biological interactions. Biomacromolecules 16:43-55|